• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Neurology

Risk of cerebral venous thrombosis increased amongst women on oral contraceptives

byShayna BejaimalandAnees Daud
March 17, 2016
in Neurology, Obstetrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this unmatched case-control study, risk of cerebral venous thrombosis (CVT) amongst women on oral contraceptives increased in a dose-dependent manner depending on their BMI category (normal, overweight, or obese).

2. There was no statistically significant association between BMI and CVT in males or in women who did not use contraceptive pills. While obesity amongst women was not an independent risk, it perhaps had an additive effect when combined with oral contraceptives.

Evidence Rating Level: 3 (Average)

Study Rundown: It is well known that obesity is associated with increased thrombosis risk, including pulmonary embolism and deep vein thrombosis. However, studies have not assessed the relationship between cerebral venous thrombosis (CVT) and obesity in adults. Established risk factors for CVT include oral contraceptive pill (OCP) use and cancer. This study assessed whether obesity was also a risk factor for CVT.

Based on this unmatched case-control study, risk of cerebral venous thrombosis (CVT) amongst women on oral contraceptives increased in a dose-dependent manner depending on their BMI category (normal, overweight, or obese). There was no significant association with increasing BMI and CVT in women who did not use OCP or amongst men. While obesity amongst women was not an independent risk, it perhaps had an additive effect when combined with oral contraceptives. Strengths of this study included assessment of previously unstudied risk factor for CVT. Limitations of this study included study design (unmatched case-control study), in which causation could not be determined. Increased BMI could have been a confounder, so further analysis would be necessary to determine the role of obesity and CVT.

Click to read the study, published today JAMA Neurology

Relevant Reading: Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions.

RELATED REPORTS

Diabetes is a risk factor for high platelet reactivity post percutaneous coronary intervention

Certain genotypes of OXTR gene may increase risk of postpartum hemorrhage

Extended rivaroxaban treatment reduces recurrence rate for patients with deep vein thrombosis

In-Depth [case-control study]: This unmatched case-control study identified cases from July 2006 to October 2009 in the Netherlands. Controls were recruited from March 1999 to September 2004. Cases were patients with confirmed CVT from two prospective cohorts in the Netherlands. Risk factor and exposure information collection was determined through standardized case report forms for cases and through self-reported questionnaires for controls. Body mass index categories were as follows: normal BMI <25, overweight BMI 25 to 29.99, and obese BMI ≥30.

The final study population included 186 cases of CVT and 6134 controls. Cases were on average younger, more often female, more often used OCPs, more frequently had a history of cancer. Initial analysis showed that patients with CVT were more likely to be obese (adjusted OR 2.63; 95%CI 1.53-4.54). When stratified by sex, there was no association between obesity and risk of CVT amongst men (aOR 1.16, 95%CI 0.25-5.30). However, women, if either overweight or obese, were associated with CVT (aOR 1.71, 95%CI 1.01-2.91 and aOR 3.50, 95%CI 2.00-6.14, respectively). When further stratified by women and OCP usage, there was no association between CVT and BMI in women who did not use OCP (aOR 1.29, 95%CI 0.46-3.66 in women with BMI ≥ 30). However, amongst women who used OCP, there was an increased risk of CVT across all BMIs, including normal (aOR 5.09, 95%CI 2.58-10.02), overweight (aOR 11.8, 95%CI 5.94-23.74), and obese (aOR 29.26, 95%CI 13.47-63.60). It is unclear if obesity has an interaction with OCPs or is a confounder in this association.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: contraceptionthrombosis
Previous Post

Chondrocyte-specific viral vector improves osteoarthritis gene therapy in mice [PreClinical]

Next Post

Parent mentors are effective at insuring uninsured children

RelatedReports

Cardiology

Diabetes is a risk factor for high platelet reactivity post percutaneous coronary intervention

December 26, 2022
No association found between length of storage for transfused red blood cells and patient mortality
Emergency

Certain genotypes of OXTR gene may increase risk of postpartum hemorrhage

December 9, 2022
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Cardiology

Extended rivaroxaban treatment reduces recurrence rate for patients with deep vein thrombosis

December 7, 2022
Paternal factors associated with short interpregnancy interval
Weekly Rewinds

2 Minute Medicine Rewind December 5, 2022

December 6, 2022
Next Post
Parent mentors are effective at insuring uninsured children

Parent mentors are effective at insuring uninsured children

Being overweight and obese associated with increased incidence of chronic kidney disease

HLA-incompatible kidney donation may increase survival compared to waiting

2 Minute Medicine Rewind October 20 – October 27, 2014

Rapid point-of-care TB test effective at reducing mortality in HIV positive patients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options